Barinthus BiotherapeuticsBRNS

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1

$86.4M

Market Cap • 24/05/2024

2016

(há 8 anos)
Fundação

2021

(3 years ago)
IPO

NASDAQ

Listagem
Flag of GB

Harwell

Valuation

Valuation Indicators

Retorno Histórico

BRNSSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

3%

1 dia

21/05/2024

-6%

1 semana

17/05/2024

-12%

1 mês

24/04/2024

10 anos

Histórico